Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-β-HSD gene localized to the region

International Journal of Cancer

Volumn 93, Issue 1, 2001, Pages 74-79

  Lin, Ya Wen ^a   Lee, I Neng ^b   Chen, Chien Hung ^a   Huang, Guan Tarn ^a   Lee, Hsuan Shu ^a   Lee, Po Huang ^a   Lu, Fung Jou ^b   Sheu, Jin Chuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CHROMOSOME 16Q; CHROMOSOME DELETION; ENVIRONMENTAL FACTOR; EXON; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TAIWAN; TUMOR SUPPRESSOR GENE;

17-HYDROXYSTEROID DEHYDROGENASES; CARCINOMA, HEPATOCELLULAR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; GENETIC MARKERS; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAIWAN;

EID: 0035399554     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1287     Document Type: Article

References (31)

1. Hepatitis B virus. The major etiology of hepatocellular carcinoma
2. Hepatitis B virus infection, its sequelae, and prevention in Taiwan
3. Mutation of p53 gene in hepatocellular carcinoma in Taiwan
4. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma
5. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
6. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
7. Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis
8. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China
9. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene
10. Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridization in Taiwan
11. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
12. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan
13. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma
14. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas
15. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas
16. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated alpha-fetoprotein production
17. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer
18. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: Identification of three independent regions
19. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region
20. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases
21. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer
22. Three independently deleted regions at chromosome arm 16q in human prostate cancer: Allelic loss at 16q24.1-q24.2 is associated with aggressive behavior of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient
23. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma
24. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer
25. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers
26. A second-generation linkage map of the human genome
27. Comprehensive allelotyping of human hepatocellular carcinoma
28. Mouse 17 beta-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts
29. Loss of estrogen inactivation in colonic cancer
30. In vivo and in vitro expression of steroid-converting enzymes in human breast tumors: Associations with interleukin-6
31. Expression of different 17β-hydroxysteroid dehydrogenase types and their activities in human prostate cancer cells